Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers.

Abstract

PURPOSE Radiopeptide therapy is commonly performed with a single radioisotope. We aimed to compare the effectiveness of somatostatin-based radiopeptide therapy with a single versus a combination of radioisotopes. PATIENTS AND METHODS In a cohort study, patients with metastasized neuroendocrine cancer were treated with repeated cycles of (90)yttrium… (More)
DOI: 10.1200/JCO.2011.37.2151

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.